Statement re: Investment

31st March 2005

                                                          FOR IMMEDIATE RELEASE

                        EUROVESTECH PLC ('Eurovestech')                        

                            Statement re Investment                            

Eurovestech announces that following a purchase of 1 50,000 shares in Prelude
Trust plc ('Prelude Trust') on 30 March 2005, Eurovestech plc ('Eurovestech')
now holds 1,675,983 shares in Prelude Trust, representing 4.57 per cent. of its
entire issued share capital .

Eurovestech began to acquire shares in Prelude Trust in September 2004, seeing
it as an interesting quoted investment opportunity, because of its focus on
early-stage technology investments and its substantial discount to net asset
value . In November 2004, Eurovestech's management met with Prelude Trust 's
management to discuss ways of addressing that discount.

Following these discussions, Prelude Trust announced on 22 November, 2004 that
its board had considered the possibility of a share buyback. I n December 2004,
Eurovestech wrote to the b oard of Prelude Trust suggesting a return of capital
programme and a reduction in the notice period for the investment management
contract from two years to one. The investment management contract was granted
by Prelude Trust in 1997 to a private company, Prelude Technology Management
Services Limited, a company which is ultimately wholly owned by Prelude
Technology Investment Holdings Limited. Dr Robert Hook and Alan Duncan, the
executive directors of Prelude Trust, are directors of Prelude Technology
Management Services Limited and Dr Hook is a trustee of the Employee Share
Ownership Plan which is the sole shareholder of Prelude Technology Investment
Holdings Limited.

On 11 December 2004, Prelude Trust replied to Eurovestech, stating that its
proposals were a matter for the full Prelude Trust board which was due to meet
in early February 2005 .

Eurovestech made its suggestion to the Prelude Trust board on the basis that
Prelude Trust 's most significant investment is cash, which the board of
Eurovestech currently estimates to represent in excess of 55 per cent. of
Prelude Trust 's market capitalisation. The board of Eurovestech estimates
that, based on the current management fee of 2.5 per cent. per annum, Prelude
Trust shareholders are paying £600,000 per annum simply to have its cash placed
on deposit, with the majority of the interest earned on the cash being paid to
Prelude Trust's manager, a company connected to some of Prelude Trust's
directors.

The board of Eurovestech believes that the failure of the board of Prelude
Trust to address these issues promptly is not in the interests of Prelude
Trust's shareholders. As a result, Eurovestech today announces that it has
advised the board of Prelude Trust that it proposes to discuss these issues
directly with Prelude Trust's other shareholders in order to actively seek ways
of maximising shareholder value.

Richard Bernstein, Chief Executive of Eurovestech said: `As a shareholder in
Prelude Trust, we are appalled to learn that it may be charged a management fee
of 2.5 per cent., which is approximately half of the interest Prelude Trust
earns on its cash by Prelude Trust's manager, simply to place the company's
funds on deposit. With the total administration costs of Prelude Trust running
at approximately £150,000 per month, a significant proportion of which is
directly attributable to the management fee, we are amazed that the directors
have not acted sooner to reduce this expenditure in the interests of all
shareholders.'


Enquiries

Richard Bernstein

Chief Executive Tel:[phone]